Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia

Steven A Kaplan,H.Logan Holtgrewe,Reginald Bruskewitz,Brian Saltzman,David Mobley,Perinchery Narayan,Robert H Lund,Steven Weiner,Glen Wells,Thomas J Cook,Alan Meehan,Joanne Waldstreicher

Urology（2001）

引用 39|浏览13

暂无评分

摘要

Objectives. To compare the efficacy and safety of finasteride 5 mg in older (65 years old or older) versus younger (45 to younger than 65 years old) men with benign prostatic hyperplasia (BPH).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要